Cardiology Online

Home

Welcome

Scientific Committees

Final Program 

Final Program (as a pdf)

IAC Awards

IAC Distinguished Fellowships

Timetable

Participant Letter

Program Topics

General Information

Instructions for the Preparation of Posters

Accommodation

Exhibition

Exhibitors

Abstract Guidelines

Contact Us

 PRESENTATION OF 2008 AWARDS

PL:01      Plenary Session
NEW THERAPEUTIC TARGETS IN CARDIOVASCULAR MEDICINE

INHIBITION OF PHOSPHOLIPASES: A NEW STRATEGY TO TREAT ATHEROSCLEROSIS AND ITS CLINICAL COMPLICATIONS? (Invited Lecture)
W. Koenig, University of Ulm, Ulm, Germany

AN UNAPPRECIATED ROLE FOR UBIQUITIN LIGASES IN EXPERIMENTAL CARDIAC HYPERTROPHY (Invited Lecture) 
C. Patterson, University of North Carolina, Chapel Hill, NC, USA

PROTEIN KINASE C ISOZYMES IN HEART DISEASE: A THERAPEUTIC OPPORTUNITY (Invited Lecture)
D. Mochly-Rosen, T. Koyanagi, J.C. Ferreira, K. Inagaki, G. Fajardo, E. Churchill, G. Budas, J.M. Tsutsui, D. Bernstein, P.C. Brum, Stanford University, Palo Alto, CA, USA

RENIN INHIBITION: A NOVEL APPROACH TO BLOOD PRESSURE CONTROL AND ORGAN PROTECTION (Invited Lecture)
A.H.J. Danser, Erasmus Medical Center, Rotterdam, The Netherlands

CARDIOPROTECTIVE ROLE OF SODIUM THIOSULFATE ON CHRONIC HEART FAILURE BY MODULATING ENDOGENOUS H2S GENERATION (Invited Lecture)
S.C. Tyagi, University of Louisville, Louisville, KY, USA

ROLE OF SARCOPLASMIC RETICULUM IN INCREASING INTRACELLULAR CA2+ DUE TO NA+-K+ ATPASE INHIBITION BY OUABAIN (Invited Lecture)
H.K. Saini-Chohan, N.S. Dhalla, University of Manitoba, Winnipeg, MB, Canada

FINDING AND VALIDATING NEW TARGETS FOR HEART FAILURE TREATMENT (Invited Lecture)
B.C. Blaxall, University of Rochester Medical Center, Rochester, NY, USA

PL:02       Plenary Session
WHAT’S NEW IN CARDIOMYOPATHIES

THE ROLE OF THE INNATE IMMUNE RESPONSE IN PROTECTING AGAINST INFECTION OF THE HEART (Invited Lecture)
N.E. Bowles, G. Vallejo, University of Utah, Salt Lake City, UT, USA

CARDIOVASCULAR EFFECTS OF CHRONIC, SUBCLINICAL EXPOSURE TO LIPOPOLYSACCHARIDE (Invited Lecture)
W.Y.W. Lew, University of California, San Diego, CA, USA

SEPSIS AND THE HEART (Invited Lecture)
M.A. Rossi, M.R. Celes, D. Torres-Duena, E.C. Campos, C.M. Prado, F.Q. Cunha, University of Sao Paulo, Ribeirao Preto, SP, Brazil

A UNIQUE CLINICAL, GENETIC AND MORPHOLOGICAL FEATURES IN HUMAN MITOCHONDRIAL CARDIOMYOPATHY (Invited Lecture)
T. Toyo-Oka, H. Hatakeyama, S. Kostin, J. Schaper, Tohoku University, Sendai, Japan

DILATED CARDIOMYOPATHY: VARIOUS ETIOLOGIES AND OUTCOME (Invited Lecture)
N.N. Kipshidze, National Center of Therapy, Tbilisi, Georgia

S21         Session
ACUTE CORONARY SYNDROMES / INTERVENTIONAL CARDIOLOGY

INTRAGRAFT ADMINISTRATION OF ABCIXIMAB AND VERAPAMIL COMBINED WITH DIRECT STENTING PREVENTS SLOW-FLOW AND NO-REFLOW PHENOMENON IN SAPHENOUS VEIN GRAFT PERCUTANEOUS CORONARY INTERVENTION
S. Sharma, J.A. Lardizabal, A. Antonescu, B. Bhambi, W. Nyitray, K. Desai, T. Ishimori, University Hospital Lewisham, London, UK

EARLY INVASIVE THERAPY VERSUS CONSERVATIVE MANAGEMENT IN ACUTE CORONARY SYNDROMES: A LONG-TERM ANALYSIS 
D.J. Kumbhani, A.A. Bavry, A.N. Rassi, D.L. Bhatt, A.T. Askari, Cleveland Clinic, Cleveland, OH, USA

THE PREDICTOR AND PREDICTIVE VALUE ASSOCIATED WITH DISTAL EMBOLIZATION FOR THE PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION - VIRTUAL HISTOLOGY INTRAVASCULAR ULTRASOUND STUDY
R. Kawaguchi, S. Oshima, H. Hoshizaki, K. Taniguchi, Gunma Prefectural Cardiovascular Center, Maebashi, Japan

LYMPHOPENIA IN ACUTE PHASE OF ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION PREDICTS LONG-TERM REINFARCTION
J. Núñez, V. Bodí, J. Sanchis, L. Mainar, G. Miñana, P.Merlos, P. Palau, E. Rumiz, E. Núñez, A. Yacer, Universitat de Valencia, Valencia, Spain

ADP-INDUCED PLATELET AGGREGATION FREQUENTLY FAILS TO DETECT IMPAIRED CLOPIDOGREL-RESPONSIVENESS IN PATIENTS WITH CORONARY ARTERY DISEASE COMPARED TO A P2Y12-SPECIFIC ASSAY – INFLUENCE OF LOW HDL
A. Schaefer, S. Weinberger, G. Ertl, J. Bauersachs, University of Wuerzburg, Wuerzburg, Germany

MECHANISM OF THE REDUCED ASPIRIN ACTION IN PATIENTS AFTER CORONARY ARTERY BY-PASS SURGERY 
T. Mattiello, R. Guerriero, L.V. Lotti, E. Trifiro', B. Pucci, P. Gazzaniga, F. Caporuscio, C .Gaudio, L. Frati, F.M. Pulcinelli, Sapienza University of Rome, Rome, Italy

BACKWARDS INTO THE FUTURE OF MYOCARDIAL REGENERATION
W. Mohl, D. Milasinovic, S. Mina, B. Syeda, G. Weigel, H. Kasahara, K. Komamura, G. Heinze, Medical University of Vienna, Vienna, Austria

CLINICAL UTILITY OF GLUCOSE-INSULIN-POTASSIUM INFUSION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: A POOLED META-ANALYSIS OF RANDOMIZED CONTROLLED CLINICAL TRIALS
S.A. Saha, S. Katragadda, J. Molnar, R.R. Arora, Sacred Heart Medical Center, Spokane, WA, USA

PATIENTS WITH ISCHEMIC STROKE, INTRACRANIAL HEMORRHAGE, AND SUBARACHNOID HEMORRHAGE WITH INCREASED TROPONIN I LEVELS HAVE INCREASED HOSPITAL MORTALITY
R. Sandhu, W.S. Aronow, A. Rajdev, R. Sukhija, H. Amin, A. Sangha, New York Medical College, Valhalla, NY, USA

TRANSIENT AND PERSISTENT WORSENING RENAL FUNCTION IN SURVIVORS OF ACUTE MYOCARDIAL INFARCTION TREATED WITH PRIMARY ANGIOPLASTY
A. Goldberg, H. Hammerman, R. Beyar, M. Kapeliovich, W. Markiewicz, A. Roguin, D. Aronson, Sieff Government Hospital, Safed, Israel, Cardiology 

INCREASING TRENDS OF ACUTE MYOCARDIAL INFARCTION IN SPAIN: THE MONICA-CATALONIA PROJECT
S. Sans, A. Puigdefabregas, G. Paluzie, D. Monterde, I. Balaguer-Vintro, Institute of Health Studies, Barcelona, Spain

S22       Session
ARTHROSCLEROSIS: PRIMARY PREVENTION, HYPERTENSION, DIABETES MELLITUS, OBESITY, METABOLIC SYNDROME

STATIN PLUS CHOLESTEROL ABSORPTION INHIBITION GIVES GREATER LDL
F.F. Samaha, N. Iqbal, D. Bregman, H. Ashfaq, M.M. Williams, University of Pennsylvania, Philadelphia, PA, USA

THE PRESENCE OF OBESITY IS STRONGLY ASSOCIATED WITH ESSENTIAL HYPERTENSION
M.R. Movahed, M. Jamal, M. Hashemzadeh, University of Arizona Sarver Heart Center, Southern Arizona VA Health Care System, Tucson, AZ, USA

IMPACT OF OBESITY ON MEASURES OF MORBIDITY AND MORTALITY IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTING
M. Alam, S.S. Virani, V. Nambi, V. Lee, M. Elayda, J.M. Wilson, C.M. Ballantyne, Baylor College of Medicine, Houston, Texas, USA

EFFECT OF REDUCTION OF IRON STORES ON VASCULAR AND CANCER OUTCOMES IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE (PAD): VA COOPERATIVE STUDY #410, THE IRON AND ATHEROSCLEROSIS STUDY (FEAST)
L.R. Zacharski, B.K. Chow, G.Shamayeva, P.W. Lavori, VA Medical Center, White River Jct., VT, Dartmouth Medical School, Lebanon, NH, USA

ADMINISTRATION OF GLUCOSE-INSULIN-POTASSIUM INFUSION IN ACUTE MYOCARDIAL INFARCTION DOES NOT REDUCE THE RISK OF CARDIOVASCULAR EVENTS AT ONE YEAR: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
S. Katragadda, S.A. Saha, R. Arora, J. Molnar, Chicago Medical School, North Chicago, IL, USA, Sacred Heart Medical Center, Spokane, WA, USA, University of Washington School of Medicine, Seattle, WA, USA

EFFECTS OF RECOMBINANT ACE2 GENE ON OXIDATIVE STRESS LEVELS IN HUMAN ENDOTHELIAL CELLS
J.C. Zhong, X.Y. Yu, Y. Huang, J.Y. Ye, Ningbo University, Ningbo, China

IMPACT OF COMPUTERIZED DECISION SUPPORT ON BLOOD PRESSURE MANAGEMENT AND CONTROL: A RANDOMIZED CONTROLLED TRIAL
L.S. Hicks, T. D. Sequist, J.Z. Ayanian, S. Shaykevich, D.F. Fairchild, E.J. Orav, D.W. Bates, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

PL:03        Plenary Session
ARRHYTHMIA AND ELECTROPHYSIOLOGY/ CARDIAC PACING AND DEFIBRILLATION/CARDIAC RESYNCHRONIZATION THERAPY

IMPACT OF NONINVASIVE TESTING ON IMPROVING IDENTIFICATION OF PATIENTS VULNERABLE TO SUSTAINED VENTRICULAR ARRHYTHMIAS (Invited Lecture)
M.E. Cain, University at Buffalo, Buffalo, NY, USA

CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE PATIENTS: HOW TO PREDICT RESPONDERS (Invited Lecture)
M.H. Pitzalis, East Carolina University, Greenville, NC, USA

DYSSYNCHRONY IN DIASTOLIC HEART FAILURE (Invited Lecture)
S.F. Nagueh, Methodist De Bakery Heart and Vascular Institute, TX, USA

HOW TO SELECT THE APPROPRIATE CANDIDATES FOR CARDIAC RESYNCHRONIZATION THERAPY (Invited Lecture)
M. Haghjoo, Iran University of Medical Sciences, Tehran, Iran

PSYCHOSOCIAL ADAPTATION AND QUALITY-OF-LIFE IN PATIENTS WITH PACEMAKERS AND IMPLANTABLE DEFIBRILLATORS (Invited Lecture)
F. Duru, University Hospital of Zurich, Zurich, Switzerland

CLINICAL CHARACTERISTICS AND RISK STRATIFICATION IN BRUGADA SYNDROME (Invited Lecture)
M. Takagi, Y. Sekiguchi, Y. Yokoyama, N. Aihara, K. Aonuma, M. Hiraoka, Osaka City University, Osaka, Japan

AN ATHLETE'S HEART MAY HARBOUR PROARRHYTHMIC CHANGES (Invited Lecture)
H. Heidbuchel, University of Leuven, Leuven, Belgium           

Long QT Syndrome: Should an ICD be Used? (Invited Lecture)
J.P. Daubert, University of Rochester Medical Center, Rochester, NY, USA          

UPDATE IN SYNCOPE MANAGEMENT. APPLICATIONS OF THE NEW GUIDELINES (Invited Lecture)
D. Flammang, La Croix Rousse University Hospital, Lyon, France       

DIAGNOSTIC AND PROGNOSTIC VALUE OF ECG CRITERIA FOR MYOCARDIAL INFARCTION IN COMPARISON WITH DELAYED-ENHANCEMENT MAGNETIC RESONANCE IMAGING (Invited Lecture)
R. Krittayaphong, Siriraj Hospital, Mahidol University, Bangkok, Thailand       

RISK STRATIFICATION WITH STRESS ECHOCARDIOGRAPHY (Invited Lecture)
A. Elhendy, Marshfield, WI, USA      

ASSESSMENT OF LEFT VENTRICULAR TORSION BY ECHOCARDIOGRAPHY: IS IT TIME TO DO THE TWIST? (Invited Lecture)
J.N. Bella, Bronx-Lebanon Hospital Center, Albert Einstein College of Medicine, Bronx, NY, USA

PROGNOSTIC VALUE OF CARDIOVASCULAR MAGNETIC RESONANCE IMAGING IN PATIENTS WITH ISCHEMIC HEART DISEASE (Invited Lecture)
V. Bodi, Hospital Clinico Universitario, Valencia, Spain

NEW ASPECTS OF ULTRASOUND CONTRAST IN CARDIOLOGY (Invited Lecture)
A.H. Jansen, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands

NON-INVASIVE ASSESSMENT OF VASCULAR LOAD AND VENTRICULAR-VASCULAR COUPLING: A FOCUS ON ECHOCARDIOGRAPHY (Invited Lecture)
J.A. Chirinos, University of Pennsylvania, VA Medical Center, Philadelphia, PA, USA

COMPARISON OF CARDIAC MDCT AND TEE IN DETECTING HIGH RISK EMBOLIC SOURCES
S.B. Ko, Y. Ko, J.H. Park, S.I Choi, EJ Chun, S.J Lee, M.K Han, H.J. Bae, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea

S23        Session
SECONDARY PREVENTION, MODIFICATION OF   LIPOPROTEINS, PROGNOSIS, RISK STRATIFICATION

OMEGA-3-ACID ETHYL ESTERS REDUCES SMALL DENSE LOW DENSITY LIPOPROTEINS REGARDLESS OF THE BASELINE LIPID PROFILE
S.M. Attia, K.H. Nader, Tanta University, Tanta, Egypt

INADEQUATE ATTAINMENT OF RECOMMENDED LIPID LEVELS IN TREATED PATIENTS
G.A. Nichols, B.M. Ambegaonkar, V. Sazonov, J.B. Brown, Kaiser Permanente Center for Health Research, Portland, OR, USA

PROGNOSTIC SIGNIFICANCE OF INCIDENT COMPLETE LEFT BUNDLE BRANCH BLOCK OBSERVED OVER A 40-YEAR PERIOD
S. Seto, R. Imanishi, S. Ichimaru, E. Nakashima, M. Akahoshi, Nagasaki University, Nagasaki, Japan

IMPAIRED GLUCOSE TOLERANCE STRONGLY AND SIGNIFICANTLY INCREASES THE RISK OF FUTURE VASCULAR EVENTS IN ANGIOGRAPHIED CORONARY PATIENTS
H. Sourij, C.H. Saely, S. Aczel, H. Jahnel, R. Zweiker, T. Marte, G. Hoefle, W. Benzer, T.C. Wascher, H. Drexel, VIVIT Institute, Feldkirch, Austria

ECONOMIC BURDEN OF ANGINA TO HEALTHCARE SYSTEMS
J.A. Kempf, E. Buysman, S. Shetty, M. Nelson, CV Therapeutics, CA, USA

A SIMPLE PROGNOSTIC CLASSIFICATION MODEL FOR POST-PROCEDURAL COMPLICATIONS FOLLOWING PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE MYOCARDIAL INFARCTION: RESULT BASED ON NEW YORK STATE PERCUTANEOUS CORONARY INTERVENTION DATABASE
A. Negassa, Albert Einstein College of Medicine, New York, USA

EFFECT OF ONCE WEEKLY ROSUVASTATIN ON LDL-C IN PATIENTS WITH PRIOR STATIN INTOLERANCE
J.M. Backes, J.F. Ruisinger, C.A. Gibson, P.M. Moriarty, Kansas University Medical Center (KUMC), Kansas City, KS, USA

HDL MORE THAN LDL: AN ACHIEVABLE GOAL
K.J. Reddy, J.R. Bangit, A.Z. Khan, M.S. Zaheer, Reddy Cardiac Wellness, Sugar Land, TX, USA

S24       Session
VASCULAR BIOLOGY, BASIC RESEARCH

OVEREXPRESSION OF CU/ZN-SUPEROXIDE DISMUTASE AND/OR CATALASE REDUCES BENZO(A)PYRENE-INDUCED ATHEROSCLEROSIS IN APOLIPOPROTEIN E-DEFICIENT MICE
Z. Guo, Meharry Medical College, TN, USA

THE ANGIOPOIETIN I +1602 A/T POLYMORPHISM ATTENUATES MICRORNA BINDING AND INCREASES RISK OF HEMORRHAGIC STROKE 
T. Yang, J. Chen, S. Yi, K. Sun, R.T. Hui, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China

THE CX3C CHEMOKINE FRACTALKINE ENHANCES VASCULAR DYSFUNCTION AND AGGRAVATES PLATELET ACTIVATION IN RATS WITH CHRONIC HEART FAILURE
A. Schaefer, C. Schulz, D. Fraccarollo, C. Schoepp, J.P. Frang, G. Ertl, S. Massberg, J. Bauersachs, University of Wuerzburg, Wuerzburg, Germany

CD40L IS UP-REGULATED BY TUMOR NECROSIS FACTOR IN PATIENTS WITH HEART FAILURE
P. Pignatelli, F. Violi, University of Rome La Sapienza, Rome, Italy

APOLIPOPROTEIN E-DEFICIENT LIPOPROTEINS INDUCE FOAM CELL FORMATION BY ACTIVATION OF UNFOLDED PROTEIN RESPONSES
H. Yang, Z. Guo, Meharry Medical College, TN, USA

THE EFFECTS OF RIVAROXABAN – AN ORAL, DIRECT FACTOR XA INHIBITOR – ON CLOT STRUCTURE AND DEGRADABILITY 
R. Varin, S. Mirshahi, P. Mirshahi, H. Li, G. Kierzek, J.F. Vigneau, E. Perzborn, M. Mirshahi, C. Soria, J. Soria,  Centre de Recherche des Cordeliers, Paris, France

DIFFERENCES BETWEEN NEW AND CLASSIC INTRAVENOUS IRON PREPARATIONS ON CARDIOVASCULAR TOXICITY IN NORMAL RATS
J.E. Toblli, G. Cao, L. Oliveri, M. Angerosa, Hospital Alemán, Buenos Aires, Argentina  

SYSTEMIC AND REGIONAL HEMODYNAMICS OF HYPOXIC PIGLETS TREATED WITH N^G-MONOMETHYL-L-ARGININE AFTER RESUSCITATION
T.F. Lee, C. Tymafichuk, P.Y. Cheung, University of Alberta, Edmonton, AB, Canada

ORAL L-ARGININE IS A REPAIRMAN BUT NOT AN ENHANCER OF ENDOTHELIAL FUNCTION: SYSTEMATIC REVIEW AND META-ANALYSIS
Y.Y. Bai, L. Sun, T. Yang, K. Sun, J.Z. Chen, R.T. Hui, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China

DIFFERENTIAL EXPRESSION OF FRACTALKINE AND MONONUCLEAR CELL RECRUITMENT BY HUMAN ARTERIAL OR VEIN ENDOTHELIAL CELLS STIMULATED WITH ANGIOTENSIN-II
M. Losada, L. Piqueras, C. Lopez-Gines, C. Company, C. Rius, M.J. Sanz, University of Valencia, Valencia, Spain

INTERLEUKIN-18 (IL-18), ENDOTHLINE-1 AND ALDOSTERONE INDUCE SMOOTH MUSCLE SENESCENCE VIA RHO-KINASE- AND PPAR- DEPENDENT PATHWAY
T. Akagami, T. Sakoda, T. Doi, T. Naka, T. Tsujino, T. Masuyama, M. Ohyanagi, Hyogo College of Medicine, Hyogo Japan

CHLAMYDIA INFECTION IN CARDIOVASCULAR PATHOLOGY: SEQUEL II
I.M. Petyaev, N.A. Zigangirova, Cambridge Theranostics Ltd., Cambridge, UK

PL:05        Plenary Session
THE RELEVANCE OF GENETICS IN PROVIDING AN
UNDERSTANDING OF CARDIOVASCULAR DISEASES

GENETICS OF CORONARY ARTERY DISEASE IN FAMILIES (Invited Lecture)
L.C. Becker, D.M. Becker, Johns Hopkins University, Baltimore, MD, USA

GENETICS OF MYOCARDIAL INFARCTION (Invited Lecture)
R. Roberts, University of Ottawa Heart Institute, Ottawa, ON, Canada

GETTING TO THE POINT: FORKHEAD TRANSCRIPTION FACTORS IN THE VASCULAR SYSTEM (Invited Lecture)
K. Maiese, Wayne State University, Detroit, MI, USA

PHARMACOGENETICS AND PHARMACOGENOMICS IN CARDIOLOGY (Invited Lecture)
H. Boudoulas, Biomedical Research Foundation, Ohio State University, Academy of Athens, Athens, Greece

GENETICS AND METABOLIC RISK OF ATHEROSCLEROSIS (Invited Lecture)
R.A. Hegele, University of Western Ontario, London, ON, Canada

IDENTIFICATION OF MI-SUSCEPTIBILITY GENES USING GENOME-WIDE LINKAGE ANALYSIS (Invited Lecture)
M. Yokota, H. Asano, S. Miyata, M. Nakatochi, M. Sukegawa, H. Izawa, Aichi-Gakuin University, Nagoya, Japan

DE-REGULATED EXPRESSION OF E2F-1 INCREASES BNIP3 AND CELL DEATH OF VENTRICULAR MYOCYTES DURING HYPOXIA (Invited Lecture)
J. Shaw, N. Yurkova, L.A. Kirshenbaum, St. Boniface General Hospital Research Centre, Winnipeg, MB, Canada

GENE-TARGETING OF NATRIURETIC PEPTIDE RECEPTOR-A REVEALS ITS ROLE IN CARDIAC HYPERTROPHY (Invited Lecture)
K.N. Pandey, Tulane University, New Orleans, LA, USA  

DNAZYMES IN THE TREATMENT OF CARDIOVASCULAR DISEASE (Invited Lecture)
V.L. Benson, L.M. Khachigian, H.C. Lowe, Concord Repatriation General Hospital, NSW, Australia

ROLE OF PHOSPHOLIPASE C IN CARDIAC HYPERTROPHY (Invited Lecture)
P.S. Tappia, University of Manitoba, Winnipeg, MB, Canada

PL:06       Plenary Session
MODIFICATION OF RISK FACTORS AND CAD, DYSLIPOPROTEINEMIA, HYPERTENSION, DIABETES MELLITUS AND METABOLIC SYNDROME

A GUIDE TO THE NEW GUIDELINES FOR THE MANAGEMENT OF HYPERTENSION (Invited Lecture)
C. Rosendorff, Mount Sinai School of Medicine, New York, NY, USA

METABOLIC SYNDROME IN CHILDHOOD AND ITS IMPACT ON ADULT HEART DISEASE: THE BOGALUSA HEART STUDY (Invited Lecture)
G.S. Berenson, Tulane University, New Orleans, LA, USA

PULSE PRESSURE, DIASTOLIC BLOOD PRESSURE AND THE J-CURVE OF CARDIOVASCULAR DISEASE RISK (Invited Lecture)
S.S. Franklin, University of California, Irvine, CA, USA

NEW TARGETS FOR CARDIOVASCULAR RISK REDUCTION IN THE METABOLIC SYNDROME: LIPOPROTEINS ARE MORE IMPORTANT THAN LIPIDS (Invited Lecture)
R.S. Rosenson, University of Michigan, Ann Arbor, MI, USA

PROTEIN KINASE A REGULATES APOLIPOPROTEIN E SECRETION BY MACROPHAGES (Invited Lecture)
L. Kritharides, University of Sydney, Sydney, NSW, Australia

HIV PROTEASE INHIBITOR RITONAVIR INHIBITS CHOLESTEROL EFFLUX FROM HUMAN MACROPHAGE-DERIVED FOAM CELLS (Invited Lecture)
C. Chen, X. Wang, H. Mu, H. Chai, D. Liao, Q. Yao, Baylor College of Medicine, Houston, TX, USA

DIETARY STRATEGIES FOR HYPERTENSION PREVENTION: PROGRESS AND PROMISE (Invited Lecture)
H.D. Sesso, Brigham & Women's Hospital, Boston, MA, USA

INTENSIVE STATIN THERAPY IN CHD - A REVIEW OF THE EVIDENCE (Invited Lecture)
K.K. Ray, University of Cambridge, Cambridge, England

COMBINATION THERAPY IN LIPID MANAGEMENT (Invited Lecture)
D. Polk, Cedars-Sinai Medical Center, Los Angeles, CA, USA

RETROSPECTIVE ANALYSIS OF LIPIDS PROFILE IN A CARDIOLOGY PRACTICE (Invited Lecture)
Y. Charuzi, J. Mirocha, T.W. Lang, Cedars Sinai Medical Center, Los Angeles, CA, USA

TACKLING THE DIABETIC PLATELET (Invited Lecture)
D.J. Angiolillo, University of Florida, Jacksonville, FL, USA 

S25         Session
ARRHYTHMIAS I: SUDDEN CARDIAC DEATH / IMPLANTABLE ANTIARRHYTHMIC DEVICES / PACING / CRT

STRONG INDEPENDENT ASSOCIATION BETWEEN TYPE 2 DIABETES MELLITUS AND THIRD DEGREE AV-BLOCK
M.R. Movahed, M. Hashemzadeh, Southern Arizona VA, Health Care System, University of Arizona, Tucson, AZ, USA

HIGH INCIDENCE OF RADIOTHERAPY-INDUCED MALFUNCTION OF PERMANENT PACEMAKERS AND ICDS: A SINGLE CENTER EXPERIENCE
D.W. Ng, F.J. Tondato, G.A. Ezzell, D. Sorajja, E. Wissner, K. Srivathsan, G.T. Altemose, M.Y. Halyard, L.R. Scott, Mayo Clinic Arizona, Scottsdale, AZ, USA

PRECORDIAL T-PEAK DISPERSION IS GREATER IN PATIENTS WITH LEFT BUNDLE BRANCH BLOCK THAN IN PATIENTS WITH RIGHT BUNDLE BRANCH BLOCK OR NARROW QRS: A NOVEL MARKER OF DYSSYNCHRONY?
G.Mark, S. Natan, E.Rhim, A.J.Greenspon, R.T. Ho, B.B. Pavri, Cooper University Hospital, Camden, NJ, USA

ECHOCARDIOGRAPHY TO PREDICT LONG-TERM REVERSE REMODELING AFTER CARDIAC RESYNCHRONIZATION THERAPY; VALUE OF QUALITATIVE OBSERVATION
A.H.M. Jansen, F. Bracke, J.M. van Dantzig, A. Meijer, C.H. Peels, P.H. van der Voort, H.H.M. Korsten, N.M. van Hemel, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands

THE IMPACT OF CARDIAC RESYNCHRONIZATION THERAPY ON KANSAS CITY CARDIOMYOPATHY QUESTIONNAIRE (KCCQ) SCORE IN PATIENTS WITH CONGESTIVE HEART FAILURE
M. Biria, J. Pillarisetti, C. Annapureddy, E. Baryun, L. Berenbom, R. Pimentel, J. Vacek, M. Emert, C. Porter, D. Lakkireddy, K. Dalton, University of Kansas Hospital, Kansas City, KS, USA

SURVIVAL IS SIMILAR AFTER STANDARD TREATMENT AND CHEST COMPRESSION ONLY IN OUT-OF-HOSPITAL BYSTANDER CARDIOPULMONARY RESUSCITATION
K.E. Bohm, M. Rosenqvist, J. Herlitz, J. Hollenberg, L. Svensson, Karolinska Institutet, Sodersjukhuset, Stockholm, Sweden

DOES SEVERITY OF SLEEP APNEA CORRELATE WITH RISK OF ARRHYTHMIC DEATH?
A.Q. Chan, E.L. Lua, M.P. Chan, Stanford University, Stanford, CA, USA

VALUE OF ROUTINE DFT TESTING AT TIME OF ICD PULSE GENERATOR REPLACEMENT
M. Singh, J. Akar,  J. Cytron, N. Varma, D. Wilber, P. Santucci, Loyola University, Maywood, IL, USA

PREVALENCE OF APPROPRIATE CARDIOVERTER-DEFIBRILLATOR SHOCKS IN 1,038 CONSECUTIVE PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
A. Kruger, W.S. Aronow, H.M. Lai, H. Desai, A. Singla, W.H. Frishman, M. Cohen, C. Sorbera, New York Medical College, Valhalla, NY, USA

EFFECT OF PACING THE RIGHT VENTRICULAR LOW SEPT TRACT IN PATIENTS WITH PERMANENT ATRIAL FIBRILLATION AND LOW EJECTION FRACTION
C. Muto, L. Ottaviano, G. Carreras, M. Canciello, R. Calvanese, L. Asocione, B. Tuccillo, S.M. Loreto Mare Hospital, Ospedale Buon Consiglio Fatebenefratelli, Napoli, Italy

OUTCOMES AND COST ANALYSIS OF TRANSVENOUS VS PROPHYLACTIC INTRAOPERATIVE IMPLANTATION OF CRT LEADS (PROPEL STUDY)
M. Biria, E. Baryun, J. Vacek, K. Dalton, M. Earnest, M. Emert, R. Pimentel, D. Lakkireddy, L. Berenbom, University of Kansas Hospital, Kansas City, KS, USA

INCIDENCE OF MORTALITY IN 1,040 PATIENTS WITH CARDIOVASCULAR DISEASE WITH NORMAL AND ABNORMAL QRS DURATION AND WITH NORMAL AND ABNORMAL LEFT VENTRICULAR EJECTION FRACTION
H.M. Lai, W.S. Aronow, A. Rajdev, A. Asija, K.V. Lai, J. George, J.A. McClung, New York Medical College, Valhalla, NY, USA

PREVALENCE AND PROGNOSIS FOR SYNCOPE AMONG CARDIAC TRANSPLANT RECIPIENTS
M.A. Caccamo, D.J. Cantillon, E.Z. Gorodeski, W. Saliba, B.L. Wilkoff, R.C. Starling, Cleveland Clinic Foundation, Cleveland, OH, USA

S26          Session
INTERVENTIONAL CARDIOLOGY

RECURRENT REVASCULARIZATION AFTER IMPLANTATION OF DRUG ELUTING STENTS: RESTENOSIS OR PROGRESSION OF ATHEROSCLEROTIC DISEASE
M. Fineschi, T. Gori, Hospital of Siena, Siena, Italy

A NEW CONCEPT OF STENT - THE MULTILAYER STENT: FIRST HUMAN STUDY IN PERIPHERAL ANEURYSM
M. Henry, A. Polydorou, N. Frid, P. Gruffaz, I. Henry, M. Hugel, Cabinet de Cardiologie, France

CONTRAST-INDUCED NEPHROPATHY AFTER LOW - OR ISO-OSMOLAR CONTRAST MEDIA USE IN HIGH RISK PATIENTS: DATA FROM THE CARE TRIAL
A. Moreyra, J. Reiner, C.S. Staniloae, S.K. Sharma, R.E. Katholi, R.J. Solomon, University of Medicine and Dentistry, New Brunswick, NJ, USA

DO DISTAL EMBOLIC PROTECTION DEVICES IMPROVE OUTCOMES OF PERCUTANEOUS TREATMENT OF SAPHENOUS VEIN GRAFT LESIONS?
A.A. Hilliard, R.J. Lennon, L.N. Hammes, C.S. Rihal, D.R. Holmes, V. Mathew, Mayo Clinic, Rochester, MN, USA

A RANDOMIZED COMPARISON OF PACLITAXEL-ELUTING STENTS VERSUS BARE-METAL STENTS FOR TREATMENT OF UNPROTECTED LEFT MAIN CORONARY ARTERY STENOSIS: LONG TERM FOLLOW-UP
A. Erglis, I. Narbute, S. Jegere, I. Kumsars, K. Trusinskis, Latvian Centre of Cardiology, Riga, Latvia

CAROTID STENTING IN SYMPTOMATIC VS. ASYMPTOMATIC PATIENTS - SINGLE CENTER EXPERIENCE FROM 600 CONSECUTIVE CAROTID INTERVENTIONS WITH NEUROPROTECTION
R. Hein, F. Beier, M. Hug, H. Strohm, H. Mudra, Städtisches Klinikum Muenchen GmbH, Klinikum Neuperlach, Munich, Germany

THE SAFETY AND EFFICACY OF GPRE-CLOSURE H UTILIZING THE CLOSERTM SUTURE-MEDIATED VASCULAR CLOSURE DEVICE FOR ACHIEVEMENT OF HEMOSTASIS IN PATIENTS FOLLOWING CORONARY INTERVENTIONS: RESULTS OF THE SECOND PERCLOSE ACCELERATED AMBULATION AND DISCHARGE (PARADISE II) TRIAL
K. Nasu, E. Tsuchikane, O. Katoh, T. Matsubara, T. Suzuki, Toyohashi Heart Center, Toyohashi, Aichi, Japan

PERCUTANEOUS CORONARY INTERVENTION IN OCTOGENARIANS: AN OUTCOME ANALYSIS
A.K. Kondur, A. Niraj, J. Pradhan, V. Veeranna, H. Fakhry, L. Afonso, Wayne State University, Detroit, MI, USA

ANACONDA ENDOVASCULAR LIMBS FOR TREATMENT OF POPLITEAL ARTERY ANEURYSMS
T. Rapanos, R. Moore, C.S. Cina, McMaster University, Hamilton, ON, Canada